Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2Sleep Initiation and Maintenance Disorders 1Postoperative Nausea and Vomiting 1Postoperative Complications 1Pain 1PGS 1Fatigue 1Depression 1Colorectal Neoplasms 1Cancer Pain 1Anxiety Disorders 1

Interventions

Sufentanil 1Electroacupuncture 1((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Postoperative Nausea and Vomiting × Electroacupuncture × 90 days × Clear all
NCT07515027 2026-04-13

Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery

Shanghai Chest Hospital

Phase NA Recruiting
204 enrolled

Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡